Sanofi SNY
NASDAQ SNY
$41.60 -0.36 (-0.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sanofi (SNY) Cash & Current Investments (2009 - 2026)

Updated

Sanofi (SNY) recorded Cash & Current Investments of $7.38 billion in the quarter ended Jun 30, 2026, down 57.5% from $17.39 billion a year earlier but up 6.5% from the prior quarter.

Analysis

Sanofi (SNY) Cash & Current Investments (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Sanofi reported Cash & Current Investments of $8.65 billion, up 7.4% from the prior year.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of -11.6% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Cash & Current Investments came in at $8.05 billion in the year ended Dec 31, 2024 (-14.5%), $9.42 billion in the year ended Dec 31, 2023 (-29.8%), $13.42 billion in the year ended Dec 31, 2022 (+12.2%) and $11.96 billion in the year ended Dec 31, 2021 (-25.5%).
  • Quarterly Cash & Current Investments has ranged from $6.93 billion in the quarter ended Mar 31, 2026 to $17.39 billion in the quarter ended Jun 30, 2025 over the past five years.
  • On a year-over-year basis, Cash & Current Investments rose in two of the last six quarters, with growth averaging 8.0%.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 137.6% in the quarter ended Jun 30, 2025, against a decline of 57.5% in the quarter ended Jun 30, 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $6.93 billion (quarter ended Mar 31, 2026), $8.91 billion (quarter ended Dec 31, 2025) and $10.41 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Sanofi 50.73 Bn 17.66 Bn 10.79 Bn 7.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.25 Bn
Mar 31, 2026 6.79 Bn
Dec 31, 2025 8.99 Bn
Sep 30, 2025 10.45 Bn
Jun 30, 2025 18.01 Bn
Mar 31, 2025 8.65 Bn
Dec 31, 2024 7.74 Bn
Jun 30, 2024 7.28 Bn
Dec 31, 2023 9.64 Bn
Jun 30, 2023 8.69 Bn
Dec 31, 2022 13.58 Bn
Jun 30, 2022 7.21 Bn
Dec 31, 2021 11.45 Bn
Jun 30, 2021 11.57 Bn
Dec 31, 2020 17.30 Bn
Jun 30, 2020 17.96 Bn
Dec 31, 2019 10.71 Bn
Jun 30, 2019 7.67 Bn
Dec 31, 2018 8.15 Bn
Sep 30, 2018 141.98 Mn
API Access

Sanofi Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SNY&period=max&api_key=YOUR_API_KEY